The validity of immunocytochemical expression of cyclin D1 in fine needle aspiration cytology of breast carcinoma

Journal of the Egyptian National Cancer Institute

Volumn 24, Issue 3, 2012, Pages 145-150

  Ezzat, Noha ^a   Hafez, Nesreen ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Breast carcinoma; Cyclin D1; FNAC

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; EGYPT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; VALIDITY;

BIOPSY, FINE-NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM GRADING; TUMOR MARKERS, BIOLOGICAL;

EID: 84865431215     PISSN: 11100362     EISSN: 16879996     Source Type: Journal    
DOI: 10.1016/j.jnci.2012.07.002     Document Type: Article

References (35)

1. " World Cancer Report" International Agency for Research on Cancer. 2008. Retrieved 2011-02-26.
2. Moktar N., Gouda I., Adel I. Cancer pathology registry 2003-2004 and time trend analysis 2007, Pathology Department, National Cancer Institute, Cairo University.
3. McGuire W.L. Breast cancer prognostic factors: evaluation guideline. J Nat Cancer Inst 1991, 83:154-155.
4. Gillett C., Smith O., Peters G., Lu X., Barness D.M. Cyclin dependent kinase, P27|kip1 expression and interaction with other cell cycle regulatory proteins in mammary carcinoma. J Pathol 1999, 187(2):200-207.
5. Motokura T., Bloom T., Kim G., Jüppner H., Ruderman J., Kronenberg H., et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991, 350:512-515.
6. Fantl V., Smith R., Brookes S., Dickson C., Peters G. Chromosome 11q13 abnormalities in human breast cancer. Cancer Surveys 1993, 18:77-937.
7. Powles T.J., Trott P.A., Cherryman G., Clark S., Ashley S., Coombes R.C., et al. Fine needle aspiration cytodiagnosis as a pre-requisite for primary medical treatment of breast cancer. Cytopathology 1991, 2:7-12.
8. Barbareschi M., Pelosio P., Caffo O., Buttitta F., Pellegrini S., Barbazza R., et al. Cyclin D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21 immunohistochemical expression. Int J Cancer 1997, 74:171-174.
9. Oyama T., Kashiwabara K., Yoshimoto K., Arnold A., Koerner F. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 1998, 58:2876-2880.
10. Buckley M.F., Sweeney K.J.E., Hamilton J.A., Sini R.L., Manning D.L., Nicholson R.I., et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8:2127-2133.
11. Prall O.W.J., Sarcevic B., Musgrove E.A., Watts C.K.W., Sutherland R.L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997, 272:10882-10894.
12. Layfield L.J., Chrischilles E.A., Cohen M.B., Bottles K. The palpable breast nodule: a cost-effective analysis of alternate diagnostic approaches. Cancer 1993, 72:1642-1651.
13. Park K., Han S., Kim H., Ko I. Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer 2001, 93:211-215.
14. Smit T.J., Safali H., Foster E.A., Reinhold R.B. Accuracy and cost-effectiveness of fine needle aspiration biopsy. Am J Surg 1985, 149:540-545.
15. Grill G.W., Frost J.K., Miller K.D. A new formula for a half oxidized hematoxylin solution that neither overstain nor requires differentiation. Acta Cytol 1974, 18:300.
16. Orell S.R. Manual and atlas of fine needle aspiration cytology 2005, 125-164. Churchill-Livingstone, New Delhi. 4th ed. S.R. Orell, G.F. Sterrett, M.N. Walters, D. Whitakar (Eds.).
17. Park K., Han S. Cytologic evaluation of p53, cyclin D1, and cathepsin D and their correlation with histologic sections in primary breast carcinoma. J Korean Breast Cancer Soc 2002, 5:113-117.
18. Reis-Filho J.S., Savage K., Lambros M.B.K., James M., Steele D., Jones R.L., et al. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Modern Pathol 2006, 19:999-1009.
19. Xiong Y., Zhang H., Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993, 7:1572-1583.
20. Amersham Pharmacia Biotech ECL Western Blotting analysis system 1998, vol. 1885. Piscataway, NJ, p. 991-995.
21. Jirstrom K., Stendahl M., Rydén L., Kronblad A., Bendahl P., Stål O., et al. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with Cyclin D1 gene amplification. Cancer Res 2005, 17:8009-8016.
22. Worsley S.D., Jennings B.A., Khalil M., Mole K.H., Girling A.C. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression. Clin Mol Pathol 1996, 49(1):M46-M50.
23. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., Sutherland R.L. C-myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 1998, 18:4499-4508.
24. Michalides R., Hageman P., Van Tinteren H., Houben L., Wientjens E., Klompmaker R., et al. A clinicopathologic study of overexpression of cyclin D1 and p53 in a series of 284 patients with operable breast cancer. Br J Cancer 1996, 73(6):728-734.
25. Zwijsen R.M., Klompmaker R., Wientjens E.B., Kristel P.M., van der Burg B., Michalides R.J. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 1996, 16:2554-2560.
26. Bartkova J., Lukas J., Muller H., Lutzhoft D., Strauss M., Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994, 57:353-361.
27. Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994, 9:707-718.
28. Lukas J., Bartkova J., Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 1996, 16:6917-6925.
29. Van Diest P., Michalides R.J.A.M., Jannink I., van der Valk P., Meijer C.J.L.M., Baak J.P.A. Cyclin D1 expression in invasive breast cancer. Correlation and prognostic value. Am J Pathol 1997, 150:705-711.
30. Han E.K.-H., Sgambato A., Jiang W., Zhang Y.-J., Santella R., Doki Y., et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995, 10:953-961.
31. Abramson V., Troxel A., Feldman M., Mies C., Wang Y., Sherman L. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome. Anticancer Res 2010, 30(4):1279-1285.
32. Han S., Kim H.Y., Park K., Lee M.S., Kim H.J., Kim Y.D. Expression of cyclin D1 protein in breast cancer and its correlation with prognosis. J Korean Surg Soc 1999, 56:771-776.
33. Simpson J.F., Quan D.E., O'Malley F., Odom-Maryon T., Clarke P.E. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 1997, 151:161-168.
34. Gillett C., Smith P., Gregory W., Richards M., Millis R., Peters G., et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996, 69:92-99.
35. Collecchi P., Passoni A., Rocchetta M., Gnesi E., Baldini E., Bevilacqua G. Cyclin-D1 expression in node-positive (N1) and node-negative (N-) infiltrating human mammary carcinomas. Int J Cancer 1999, 84:139-144.